Explainable machine learning for predicting recurrence-free survival in endometrial carcinosarcoma patients.
Journal:
Frontiers in artificial intelligence
Published Date:
Dec 6, 2024
Abstract
OBJECTIVES: Endometrial carcinosarcoma is a rare, aggressive high-grade endometrial cancer, accounting for about 5% of all uterine cancers and 15% of deaths from uterine cancers. The treatment can be complex, and the prognosis is poor. Its increasing incidence underscores the urgent requirement for personalized approaches in managing such challenging diseases.
Authors
Keywords
No keywords available for this article.